Everything about Forex

Geron Corp. shares rallied early Friday on news that the U.S. Food and Drug Administration is allowing the company to proceed with the world s first clinical study to test an embryonic-stem-cell therapy on humans.
Lesen hier die vollständige Nachricht

Kommentar schreiben

Name (required)

Mail (will not be published) (required)

Website

- UPDATE – HudBay operating results rise; NYSE listing planned (at Reuters)

- BMW in voller Beschleunigung

- US-Behörde brummt UBS Mio.-Busse auf

- [$$] Old Favorites Day (at TheStreet.com)

- Crush of mud finally plugs BP’s well in the Gulf

- Stocks rise on economic data